Tag: bisantrene cGMP API manufacturing
Aussie biotech firm completes bisantrene cGMP API manufacturing with Indian partner
Race Oncology Limited announced that Laurus Labs, an India-based pharmaceutical manufacturer, has produced its first batch of bisantrene dihydrochloride, Race’s active pharmaceutical ingredient (API), to a standard that meets the quality specified under the ‘Code of Good Manufacturing Practice’ (cGMP).
Featured Article
Embracing the future: Australian manufacturing trends in 2025
As the calendar turns to 2025, the Australian manufacturing sector stands at the cusp of transformation.
